Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells

Kim De Veirman(Vrije Universiteit Brussel), Els Van Valckenborgh(Sciensano (Belgium))

Oncotarget

March 23, 2015

10.18632/oncotarget.3300

Cited by 70

Related Papers

Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma

|Journal for ImmunoTherapy of Cancer|2023|19

Targeting the β <sub>2</sub> ‐adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism

|The Journal of Pathology|2022|16

Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia

|Blood Cancer Journal|2023|15